Vasculitis

February 24, 2022

Anisha Dua, MD, MPH, discusses the mimics, related conditions, and new diseases in the field of vasculitis as it relates to rheumatology.

March 25, 2021

Patients with inflammatory rheumatic diseases (IRD) may be more likely to acquire severe pneumonia due to COVID-19, especially in patients with autoimmune disease who are being treated with rituximab.

March 24, 2020

Despite the publication of previous clinical trials that showed plasma exchange could possibly be a viable treatment for patients with severe ANCA-associated vasculitis, a new study recently published in the New England Journal of Medicine shows the treatment, in combination with standard therapy, didn't improve outcomes for patients or lower fatality rates or slow the progression to end-stage kidney disease.

January 31, 2020

A 20-month-old boy with skin peeling, a strawberry red tongue and swelling of the hands and feet. Can you diagnose this patient?

October 01, 2019

The U.S. Food and Drug Administration has approved rituximab (Rituxan, Genentech) for the treatment of granulomatosis with polyangiitis (GPA) and microscopic polyangiitis (MPA) in children 2 years of age and older in combination with glucocorticoids.

July 19, 2019

The European League Against Rheumatism has updated treatment guidelines for the management of large vessel vasculitis. Among the changes, the task force no longer recommends the routine use of antiplatelet or anticoagulant therapy. Learn more in this slideshow.

March 01, 2018

Ultrasound, MRI, PET, CT, MRA, CTA: guidance here on when to use which imaging technique.

February 07, 2018

An online tool for juvenile arthritis, guidelines on childhood lupus, and good news about the response to treatment for ANCA-associated vasculitis

December 21, 2017

Mepolizumab gets the nod for the rare disease formerly known as Churg-Strauss syndrome.

October 11, 2017

Continuing azathioprine and prednisolone past 2 years from diagnosis was superior to withholding them.